Literature DB >> 19297465

The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.

Reena Ghildyal1, Adeline Ho, Manisha Dias, Lydia Soegiyono, Phillip G Bardin, Kim C Tran, Michael N Teng, David A Jans.   

Abstract

The respiratory syncytial virus (RSV) matrix (M) protein is localized in the nucleus of infected cells early in infection but is mostly cytoplasmic late in infection. We have previously shown that M localizes in the nucleus through the action of the importin beta1 nuclear import receptor. Here, we establish for the first time that M's ability to shuttle to the cytoplasm is due to the action of the nuclear export receptor Crm1, as shown in infected cells, and in cells transfected to express green fluorescent protein (GFP)-M fusion proteins. Specific inhibition of Crm1-mediated nuclear export by leptomycin B increased M nuclear accumulation. Analysis of truncated and point-mutated M derivatives indicated that Crm1-dependent nuclear export of M is attributable to a nuclear export signal (NES) within residues 194 to 206. Importantly, inhibition of M nuclear export resulted in reduced virus production, and a recombinant RSV carrying a mutated NES could not be rescued by reverse genetics. That this is likely to be due to the inability of a nuclear export deficient M to localize to regions of virus assembly is indicated by the fact that a nuclear-export-deficient GFP-M fails to localize to regions of virus assembly when expressed in cells infected with wild-type RSV. Together, our data suggest that Crm1-dependent nuclear export of M is central to RSV infection, representing the first report of such a mechanism for a paramyxovirus M protein and with important implications for related paramyxoviruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297465      PMCID: PMC2681974          DOI: 10.1128/JVI.02374-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids.

Authors:  P E Kaptur; R B Rhodes; D S Lyles
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.

Authors:  C Orvell; E Norrby; M A Mufson
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

3.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

4.  Nuclear entry and nucleolar localization of the Newcastle disease virus (NDV) matrix protein occur early in infection and do not require other NDV proteins.

Authors:  M E Peeples; C Wang; K C Gupta; N Coleman
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Vesicular stomatitis virus M protein in the nuclei of infected cells.

Authors:  D S Lyles; L Puddington; B J McCreedy
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Freeze-drying of respiratory syncytial viruses for transportation and storage.

Authors:  G A Tannock; J C Hierholzer; D A Bryce; C F Chee; J A Paul
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

8.  Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.

Authors:  N Kudo; B Wolff; T Sekimoto; E P Schreiner; Y Yoneda; M Yanagida; S Horinouchi; M Yoshida
Journal:  Exp Cell Res       Date:  1998-08-01       Impact factor: 3.905

9.  Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein.

Authors:  J García; B García-Barreno; A Vivo; J A Melero
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

10.  Direct observation of the budding and fusion of an enveloped virus by video microscopy of viable cells.

Authors:  T Bächi
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

View more
  54 in total

1.  A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication.

Authors:  Shuai Cao; Xiaoling Liu; Maorong Yu; Jing Li; Xiaojuan Jia; Yuhai Bi; Lei Sun; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 2.  Paramyxovirus assembly and budding: building particles that transmit infections.

Authors:  Megan S Harrison; Takemasa Sakaguchi; Anthony P Schmitt
Journal:  Int J Biochem Cell Biol       Date:  2010-04-14       Impact factor: 5.085

3.  Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Authors:  Naoto Ito; Gregory W Moseley; Danielle Blondel; Kenta Shimizu; Caitlin L Rowe; Yuki Ito; Tatsunori Masatani; Keisuke Nakagawa; David A Jans; Makoto Sugiyama
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

4.  Nuclear localization of non-structural protein 3 (NS3) during dengue virus infection.

Authors:  Selvin Noé Palacios-Rápalo; Luis Adrián De Jesús-González; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Noe Farfan-Morales; Ana Lorena Gutiérrez-Escolano; Rosa María Del Ángel
Journal:  Arch Virol       Date:  2021-03-08       Impact factor: 2.574

5.  Mechanisms and consequences of Newcastle disease virus W protein subcellular localization in the nucleus or mitochondria.

Authors:  Yanling Yang; Jia Xue; Qingyuan Teng; Xiao Li; Yawen Bu; Guozhong Zhang
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 6.  Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design.

Authors:  Janyra A Espinoza; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

7.  Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.

Authors:  Yao E Wang; Arnold Park; Michael Lake; Mickey Pentecost; Betsabe Torres; Tatyana E Yun; Mike C Wolf; Michael R Holbrook; Alexander N Freiberg; Benhur Lee
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

8.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

9.  Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Authors:  Olivia Perwitasari; Scott Johnson; Xiuzhen Yan; Elizabeth Howerth; Sharon Shacham; Yosef Landesman; Erkan Baloglu; Dilara McCauley; Sharon Tamir; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Functional correlations of respiratory syncytial virus proteins to intrinsic disorder.

Authors:  Jillian N Whelan; Krishna D Reddy; Vladimir N Uversky; Michael N Teng
Journal:  Mol Biosyst       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.